You are here: Industry Insights > SARS-CoV-2

News List

Co-Diagnostics JV CoSara Receives Clearance from Indian FDA for COVID-19 2-Gene Multiplex Test prnewswire
November 26, 2020
Co-Diagnostics, Inc., a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced that CoSara Diagnostics Pvt Ltd, its joint venture for manufacturing and sales in India, has received ...
FDA Authorizes COVID-19 Test for Self-Testing at Home americanpharmaceuticalreview
November 26, 2020
The U.S. Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for the first COVID-19 diagnostic test for self-testing at home and provides rapid results.
Clear Creek Bio doses first patient in phase 2 outpatient study of Brequinar to treat Covid-19 pharmaceutical-business-review
November 25, 2020
Clear Creek Bio, Inc. announced that the company has dosed the first patient in the CRISIS2 study, a Phase 2 clinical study evaluating brequinar for the treatment of Covid-19.
Koru Lifescience preparing to send drug compounds to preclinical and clinical trials based on their study for Covid-19 prnasia
November 24, 2020
Koru Lifescience, drug discovery, and advanced formulation research laboratory in Auckland, New Zealand, has identified several known drug compounds of value in their study for a treatment of Covid-19.
Sosei Heptares’ COVID-19 programme advances promising molecules pharmatimes
November 23, 2020
Japanese pharma company Sosei Heptares has identified and advanced the ‘most promising’ molecules in its COVID-19 research and development programme.
COG-UK Consortium gets £12.2 mn for COVID-19 genomic surveillance expresspharma
November 23, 2020
Since its launch in March 2020, COG-UK has generated and made publicly available more than 100,000 SARS-CoV-2 genomes.
Immunological memory after cured Sars-CoV-2 infection worldpharmanews
November 20, 2020
Until now, it was unclear whether a survived SARS-CoV-2 infection or COVID-19 leads to a persistent immunological memory and thus can protect against a new infection.
Chinese vaccine candidate based on inactivated SARS-CoV-2 virus appears safe and induces an immune response in healthy volunteers worldpharmanews
November 20, 2020
Results from an early-phase randomised clinical trial of a Chinese vaccine candidate based on the inactivated whole SARS-CoV-2 virus (CoronaVac) are published in The Lancet Infectious Diseases journal, finding the formulation appears safe and induces ...
Eurofins Viracor Diagnostics Launches Combined Test For COVID-19, Influenza, And RSV As The Flu Season Approaches prnewswire
November 19, 2020
Eurofins Viracor, a leading infectious disease testing laboratory for more than 35 years, announces the launch of several combined tests which detect COVID-19, influenza A/B, and respiratory syncytial virus (RSV).
GenScript Receives EUA for SARS-CoV-2 Neutralizing Antibody Detection Kit americanpharmaceuticalreview
November 18, 2020
GenScript USA announced the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for the cPass™ SARS-CoV-2 Neutralization Antibody Detection Kit.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 61 62 Next page